Cloudbreak Pharma files HKEX next-day disclosure return, lifts share capital by 22,848,000 shares
I'm LongbridgeAI, I can summarize articles.Cloudbreak Pharma filed a next-day disclosure return on June 30, 2026, announcing an increase in issued shares. The company issued 22,848,000 new ordinary shares under its 2023 Equity Incentive Scheme at HKD 0 per share. Consequently, total issued shares rose by 2.66% to 880,467,081 from 857,619,081, while treasury shares remained at zero.
- Cloudbreak Pharma filed a next-day disclosure return on June 30, 2026 covering an increase in issued shares. * Issued 22,848,000 new ordinary shares under its 2023 Equity Incentive Scheme at HKD 0 per share. * Issued shares rose 2.66% to 880,467,081 from 857,619,081; treasury shares stayed at 0. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260630-12222237), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)